News | Treatment Planning | May 02, 2016

Mirada Medical Showcases Latest Radiotherapy Advancements at 35th ESTRO Congress

Company will highlight RTx planning software and Workflow Box for adaptive contouring

Mirada Medical, 35th ESTRO Congress, radiotherapy treatment planning, RTx, Workflow Box

RTx software image courtesy of Mirada Medical

May 2, 2016 — Mirada Medical announced it will showcase its latest solutions for radiotherapy, including RTx and Workflow Box, at the European Society for Radiation Oncology (ESTRO) 2016 Congress, April 29-May 2 in Torino, Italy.

The number and types of images — computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI) — used for modern protocols has significantly increased in the past years. This has created the daily challenge of precise and accurate alignment of the different images.

Having recently acquired the Mirada RTx solution for The Christie NHS Foundation Trust in Manchester, U.K., Prof. Marcel Van Herk declared: “We have chosen Mirada as strategic partner to develop multimodality imaging solutions because of the quality of their software, allowing rapid translation of novel techniques into our clinic while also providing the possibility to efficiently integrate workflows for the different treatment techniques that are available at our site.”

Modern protocols such as image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT) or volumetric modulated arc therapy (VMAT) also require thin-slice imaging to precisely target disease and spare healthy tissue, which has created a significant burden in manual contouring. While several vendors have introduced auto-contouring, Mirada is showcasing what it claims is the only zero-click, truly automated multi-atlas contouring solution. The Mirada solution employs unique SMART (Scalable Multi-Atlas for Radiation Therapy) technology and relies on the Mirada image registration engine. It is designed to save time and improve consistency for initial contouring and adaptive re-contouring. Being vendor-agnostic, it also integrates seamlessly into any radiotherapy workflow.

Further, through the course of radiotherapy, patient anatomy may change. In addition, changes in the shape, size and position of targeted disease are likely. It is a daily challenge to assess whether the treatment plan needs to be updated to account for these changes. Mirada RTx turns the complex task of adaptive assessment into a rapid and accurate multi-timepoint comparison of images, structures and doses. With its zero-click SMART contouring solution Workflow Box, Mirada automates the previously laborious task of adaptive re-contouring.

“Technology is a major part of our treatment and workflow improvement strategy. We chose Mirada because their contouring solution allows us the flexibility to push boundaries in research whilst using robust workflows we can trust in a clinical setting as well. With growing patient numbers and treatment complexity, increasing efficiency and flexibility whilst improving quality and precision has become imperative.”  said Peter Remeijer, Ph.D., from Dutch Cancer Institute Antoni Van Leeuwen NKI, Amsterdam.

For more information:

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation